GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Jumpcan Pharmaceutical Co Ltd (SHSE:600566) » Definitions » Sale Of Investment

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Sale Of Investment : ¥5,455 Mil (TTM As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Hubei Jumpcan Pharmaceutical Co Sale Of Investment?

Hubei Jumpcan Pharmaceutical Co's sale of investment for the three months ended in Mar. 2024 was ¥2,119 Mil. It means Hubei Jumpcan Pharmaceutical Co gained ¥2,119 Mil from selling investments. Hubei Jumpcan Pharmaceutical Co's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was ¥5,455 Mil.

Compared with last quarter (¥702 Mil in Dec. 2023 ), Hubei Jumpcan Pharmaceutical Co gained more money from selling investments in Mar. 2024 (¥2,119 Mil).


Hubei Jumpcan Pharmaceutical Co Sale Of Investment Historical Data

The historical data trend for Hubei Jumpcan Pharmaceutical Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Jumpcan Pharmaceutical Co Sale Of Investment Chart

Hubei Jumpcan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 782.31 680.60 4,401.16 4,868.53 4,735.44

Hubei Jumpcan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,399.25 1,284.13 1,349.73 702.32 2,118.90

Hubei Jumpcan Pharmaceutical Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥5,455 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hubei Jumpcan Pharmaceutical Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Hubei Jumpcan Pharmaceutical Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Business Description

Traded in Other Exchanges
N/A
Address
Heights Garden Road, Room 602 fashion, Shashi District, Jingzhou, Hubei, CHN
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatric. The company also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.
Executives
Cao Wei Directors, senior managers
Zhou Qi Hua senior management
Huang Qu Rong Director
Yan Hong Quan senior management
Shi Wen Zheng senior management
Zhang Jian Min Director
Cao Long Xiang Director
Yan Yue Hua Director

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Headlines

No Headlines